Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
Chemotherapy|February 1, 2014
Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbineHisao Imai, Takehito Shukuya, Reiko Yoshino, et al.
Cancer Medicine|September 29, 2021
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutationHiroaki Kodama, Hirotsugu Kenmotsu, Takanori Kawabata, et al.
BMC Cancer|November 9, 2016
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patientsRyo Ko, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
Cancer|April 5, 2014
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute studyMasakuni Serizawa, Yasuhiro Koh, Hirotsugu Kenmotsu, et al.
Cancer Medicine|December 10, 2020
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancerNaoya Nishioka, Tateaki Naito, Akifumi Notsu, et al.
Respiratory Investigation|October 4, 2024
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance statusKazuhisa Nakashima, Hiroaki Kodama, Haruyasu Murakami, et al.
European Journal of Radiology|November 8, 2011
18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological studyKyoichi Kaira, Masato Abe, Kazuo Nakagawa, et al.
Cancer Science|October 24, 2020
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapyTaichi Miyawaki, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.
Investigational New Drugs|October 11, 2021
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancerAri Nishimura, Akira Ono, Kazushige Wakuda, et al.
Respiratory Investigation|December 4, 2012
Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in JapanHirotsugu Kenmotsu, Yasuhisa Ohde, Takehito Shukuya, et al.
Pageof 26